Month: September 2020

NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) — NewHold Investment Corp. (NASD: NHICU) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 17,250,000 units completed on July 30, 2020 (the “offering”) may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about September 22, 2020. Any units not separated will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “NHICU”, and each of the shares of Class A common stock and the warrants will separately trade on the Nasdaq under the symbols “NHIC” and “NHICW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact...

IRVINE, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — CorVel Corporation (NASDAQ: CRVL) was named Third Party Association Team of the Year at the Business Insurance U.S. Insurance Awards on September 10 for its innovative work with the State of Tennessee. The award honors teams of professionals that accomplish major achievements and demonstrate excellence in the commercial insurance and risk management sector.The State of Tennessee partnered with CorVel to increase the efficiency and cost-effectiveness of its program by leveraging CorVel’s integrated claims management services. Over the past two years, CorVel helped Tennessee implement a statewide return-to-work program, comprehensive pharmacy solutions, and an innovative intake process that includes 24/7 nurse triage and virtual care through telehealth. CorVel’s team effectively managed...

RESOLUTIONSof the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 2020Report of the Board on results of operations in 2019.Resolution:To take notice of the Report of the Board of the JSC “Olainfarm” on results of operations in 2019.Voting results:  decision is taken with the required majority of votes.Report of the Council on results of operations in 2019.Resolution:To take notice of the Report of the Council of the JSC “Olainfarm” on results of operations in 2019.Voting results:  decision is taken with the required majority of votes.Approval of the JSC “Olainfarm”  Consolidated Annual Report for 2019.Resolution:To approve the Consolidated and Parent Company’s Annual Report of JSC „Olainfarm” for 2019 with profit in amount of EUR 22 239 000,00.Voting results:  decision is taken with the required majority...

Akciju sabiedrības “Olainfarm”, reģistrācijas numurs 40003007246, kārtējās 2020.gada 22.septembra akcionāru sapulcesLĒMUMIValdes ziņojums par 2019. gada darbības rezultātiemLēmums:Pieņemt zināšanai akciju sabiedrības “Olainfarm” valdes ziņojumu par 2019.gada darbības rezultātiem.Balsošanas rezultāti: lēmums pieņemts ar nepieciešamo balsu vairākumu.Padomes ziņojums par 2019. gada darbības rezultātiemLēmums:Pieņemt zināšanai akciju sabiedrības “Olainfarm” padomes ziņojumu par 2019.gada darbības rezultātiem.Balsošanas rezultāti: lēmums pieņemts ar nepieciešamo balsu vairākumu.Akciju sabiedrības „Olainfarm” 2019. gada konsolidētā gada pārskata apstiprināšanaLēmums:Apstiprināt akciju sabiedrības „Olainfarm” 2019. gada konsolidēto un mātes sabiedrības gada pārskatu, ar peļņu 22 239 000,00 euro apmērā.Balsošanas rezultāti: lēmums pieņemts ar...

BARRIE, Ontario, Sept. 22, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary MediPharm Labs Inc. will supply premium, GMP-certified formulated cannabis oil to XLR8 BRAZIL (“XLR8”), a Rio de Janeiro based value-added distributor serving Brazil, Latin America’s largest medical cannabis market.Under the two-year agreement commencing from the time of product authorization, MediPharm Labs Inc. will provide a variety of cannabis concentrate formats for patient-ready formulated products that will be distributed by XLR8 to leading pharmacies and other authorized channels in Brazil. The initial product...

ELGIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the opening of its newest community in the Austin market, Homestead Estates, offering an astounding line up of superior-quality homes with home prices starting in the $210s.Ideally located in Elgin, Texas, Homestead Estates is situated less than five minutes from Highway 290, allowing residents to get anywhere quickly. This premier location places homeowners in great proximity to downtown Austin, several local attractions, great shopping, dining and a host of major employers. Inside the community, LGI Homes is constructing a brand-new park with a children’s playground and a covered picnic pavilion. For those residents who live a more active lifestyle, there will also be a sand volleyball court and a community soccer field. Additionally,...

MISSISSAUGA, Ontario, Sept. 22, 2020 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it is has been invited to present about the performance of its COVID-19 in-vitro diagnostics (IVD) quality assessment products at “ECCVID,” a virtual conference on Coronavirus disease organized by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), taking place September 23-25, 2020.The abstract presentation is titled “Novel SARS-CoV-2 Full-Genome Material For Use In A Swab-based Formulation As A Multi-Platform NAAT Quality Control.” It reviews the performance of Microbix’s novel, innovative, and proprietary REDx™FLOQ® SARS-CoV-2 product – A tool for helping to ensure the accuracy of clinical laboratory “RT-PCR” testing...

WOBURN, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported the launch of the Quell Watch App, now available for download from the Apple App store.Quell is a wearable, transcutaneous electrical nerve stimulation (TENS) device for knee, foot and leg pain that is available over-the-counter. It can be used during the day while active and at night while sleeping. Users can personalize and manage therapy discreetly via the mobile app for iPhone and Android smartphones. Quell is also a pain management solution with pain, sleep, activity and gait tracking. The Quell Health Cloud® provides customized feedback and powers one of the largest chronic pain outcomes databases. To learn more visit www.QuellRelief.com.Like Quell, a smartwatch is always on the body. This enables a high level of integration and...

AUSTIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial stage biotech company, CEO Denis Corin, who discusses initial commercial uptake of Strontium89, its FDA approved drug for the non-opioid treatment of metastatic cancer in the bone. Corin added context and his insights into the other Company news regarding the GMP production contract has been initiated for MAN-19, a clinical grade therapeutic intended to treat complications caused by COVID-19. The Phase 1 clinical trial is slated to begin patient enrollment in February 2021.Denis Corin, CEO of Q BioMed, added, “We believe we have created a highly valuable pipeline of assets we hope to advance towards the patient populations we intend to...